Tropicamide
Back to searchMolecule Structure
Scientific Name
Tropicamide
Description of the Drug
Tropicamide is a muscarinic receptor antagonist used to induce mydriasis and cycloplegia for diagnostic procedures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00809
http://www.drugbank.ca/drugs/DB00809
Brand Name(s)
Mydriacyl, Mydriafair, Nods, Tropicacyl, Tropicamide
Company Owner(s)
Akorn Operating Co Llc, Miza Pharmaceuticals Usa Inc, Sandoz Inc, Watson Laboratories Inc, Alcon Laboratories Inc, Alcon Pharmaceuticals Ltd, Pharmafair Inc, Bausch And Lomb Pharmaceuticals Inc, Bausch And Lomb Inc, Somerset Therapeutics Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL23975 | |
| PharmGKB | PA164749389 | |
| Human Metabolome Database | HMDB0014947 | |
| DrugBank | DB00809 | |
| PubChem: Thomson Pharma | 14751045 | |
| PubChem | 5593 | |
| Mcule | MCULE-4102613027 | |
| LINCS | LSM-1814 | |
| Nikkaji | J3.670F | |
| BindingDB | 82371 | |
| EPA CompTox Dashboard | DTXSID8045220 | |
| DrugCentral | 2774 | |
| ChemicalBook | CB31018919 | CB9337073 |
| Guide to Pharmacology | 7319 | |
| rxnorm | MYDRIACYL | TROPICAMIDE |
| ChEBI | 9757 |
